Pfizer, Starboard Value
Ex-Pfizer Execs Backed Its Leadership. An Activist Investor Says They Were 'Threatened'
Two former Pfizer executives published a statement saying they support the current company management as it gets pressured for changes by activist investor Starboard Value.
Pfizer’s stock dips after two former execs say they won’t support Starboard
Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current management.
Activist Accuses Pfizer of Pressuring Former Executives
Two former Pfizer top executives won’t participate in an activist investor’s effort to pressure the drugmaker to make changes to improve its performance.
Pfizer Stock Soars as Activist Investor Starboard Takes $1 Billion Stake
Pfizer's (PFE, Financial) stock experienced a boost on Monday, surging by 3 %, following the news that activist investor Starboard Value has acquired a substantial stake in the pharmaceutical giant. The investment,
Activist investor Starboard accuses Pfizer of strong-arming former execs into backing CEO Bourla ahead of strategy meeting
Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting with activist investor Starboard Value, Pfizer's former CEO and CFO publicly changed their tune after being threatened with litigation by Pfizer,
Activist investor claims Pfizer coerced former execs amid power struggle
As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard Value.
Pfizer's CEO gains support of ex-execs amid activist investor talks
"We have decided not to be involved in the efforts of Starboard Value regarding Pfizer. We are fully supportive of Pfizer Chairman & CEO Albert Bourla, senior management and the board, and we are confident that over time they will deliver shareholder value," the two wrote, in a statement issued on behalf of them by Guggenheim Securities.
Former Pfizer CEO, CFO say they will not be involved in Starboard's campaign against drugmaker
Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, which reportedly wants the U.S. drug giant to make changes to turn its performance around.
Activist Investor Starboard Value Accuses Pfizer Of Pressure Former Execs To Halt Support For Its...
Activist investor Starboard Value accused Pfizer of pressuring its former CEO Ian Read and ex-CFO Frank D’Amelio to halt support for Starboard’s turnaround campaign. Starboard’s Jeff Smith revealed the company allegedly threatened to claw back compensation and cancel unvested shares.
Pfizer's ex-CEO won't be involved in Starboard Value effort
Ex-CEO Ian Read and former CFO Frank D’Amelio said they are “fully supportive” of Pfizer’s current CEO, senior management and board of directors.
STAT2d
A crack of light for Pfizer
Pfizer shared that the combination of its drugs Talzenna and Xtandi extended survival in men with metastatic ...
Former Pfizer CEO, finance chief step back from Starboard's activist campaign
The about face comes as the board grapples with the activist's efforts, and just days before Starboard's Jeff Smith was ...
Pfizer’s Leadership Stability and Activist Investor Watch: A Hold Rating Analysis
Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating on October 7. David ...
GEN2h
StockWatch: Investors Unfazed by Illumina’s MiSeq Product Launches, Starboard’s $1B Stake in Pfizer
Investors shrugged as Illumina pressed its case for building on its longtime leadership in next-generation sequencing, ...